The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients. [electronic resource]
Producer: 20121004Description: 1386-96 p. digitalISSN:- 1365-2036
- Adult
- Analysis of Variance
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Clinical Trials as Topic
- Colitis, Ulcerative -- drug therapy
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Male
- Mesalamine -- administration & dosage
- Middle Aged
- Quality of Life
- Severity of Illness Index
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.